Checkpoint Therapeutics Inc. (NASDAQ: CKPT) Highlighted for Surprising Price Action

Stock Information for Checkpoint Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Checkpoint Therapeutics Inc.

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders
CHECKPOINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkpoint Therapeutics, Inc. - CKPT
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RKDA, CKPT, QTRX on Behalf of Shareholders
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - BRDG, AKYA, CKPT, QTRX
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger - BRDG, AKYA, CKPT, QTRX

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.